chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from  a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 23-MAR-2017 (also reported as 24-MAR-2017), the patient was vaccinated  with a dose of M-M-R II lot # M028130 and expiration date of 06-JUN-2018 (strength and dose were unknown) for prophylaxis and with a dose of VARIVAX lot # M036272 and expiration date of 17-AUG-2018  (strength and dose were unknown) for the same indication. Both vaccines were administered intramuscularly rather than subcutaneously. No adverse effects were reported. Additional information has been requested.
chills; headache; joint pain; nose was burning; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on 25Jan2021 as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient took the 1st dose after a week experienced chills, headache, joint pain and nose was burning on an unspecified date in Feb2021. The outcome of the events was unknown.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.  Information about lot/batch number has been requested.
Pt rcvd adult dose of Covid-19 Pfizer vaccine.  Unable to reach parent x 2 days.  Left voicemail x2.
Pt recvd vax & following dose pt's asthma got worse, pt was allergic to yeast;
patient stated he was red and itchy and starting to devolpe hives.  I advised him to take some benadryl and contact his md
It was reported that a 47 year old female received Fluzone SV '99-'00 on 10/20/99. "One hour, post vax, she developed generalized urticaria and itching." No further information is available at this time.
after her first dose, she just had a sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 08:30 (Lot number: EN6202) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "after her first dose, she just had a sore arm".  No follow-up attempts are possible. No further information is expected.
Swollen, red upper bicep on LUE at injection site. Circumferential erythema around site.
Pt recvd 1st dose of hep B vax & later devel a rash on torso,arms & legs w/ "red blotches".Tx w/ Cortaid & Aveeno lotion, later blotches dries and left skin discoloration.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  It was reported that the vaccine was stored in the freezer and they would take out one to two vials and keep in the fridge as needed each day.  It was reported that no treatment was provided to the patients.
Red/swollen area on right leg on 7/3/14 and resolved on 7/7/14 no treatment needed.
This spontaneous report as received from a physician via company representative refers to a 60 year old female patient with pertinent medical history of seizures. The patient had no drug allergies or reactions. On 28-JUN-2014 the patient was vaccinated with 1 single shot of ZOSTAVAX, subcutaneous injection. On an unknown date, approximately on 05-JUL-2014 (reported as "1 week after administration") the patient presented with Lichen Planus, one spot on each wrist, which had since spread to other parts of her body. The patient sought medical attention. The treatment included CLOBETASOL and two unspecified steroid injections (dosages, frequencies and routes of administration unknown). On an unkonwn date there was unspecified biopsy performed. No results were reported. The outcome of Lichen Planus was reported as not recovered. The relatedness between the adverse event and ZOSTAVAX was not reported. Additional information has been requested.
a 79 y.o. female who presented on 10/28/2021 with a 4 day complaint of cough, congestion and shortness of breath and found to be COVID-19 positive (confirmed 10/28/2021), CXR was negative for infiltrates. The patient is vaccinated for COVID 19. She was initially hypoxic in the ED requiring 2L NC but has since been weaned to room air. The patient received treatment with 4 days of remdesivir and decadron. Decadron will be continued upon discharge to complete a total of 10 days of therapy. The patient was planning to discharge back there. However given her COVID-19 positive status she will be returning home until her 10-day quarantine period is complete per the facilities guidelines and will follow-up with the patient at her home. Recommend post-hospital follow-up with PCP in 1-week.
Severe fatigue-continually tried to get up and stay up out of bed longer than 10 minutes just kept feeling faint and had to get back to bed. Once there sleepy 1-2 hours at a time. This lasted about 28-30 hour, weakness and not able to keep soft up right or do light cleanin. Tookmany naps and stayed in bed. This lasted about 28-30 hours. Head ache, dizziness, injection site pain for two days. Took pain reliever, Tylenol, and used a hot pad on injection site.
Site: Pain at Injection Site-Mild, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe
Approximately 6 months after my body broke out in what appeared to be a serious case of eczema . Never had this before. It was untreatable by topical and needed oral steroids to slow it down. My wife who was vaccinated two weeks after I, just experienced the same eczema problem, two weeks after my first reaction.  She is pregnant, and also has never had eczema before. Both were very serious cases and my wife needed to be hospitalized due to it.
3 days post inj -developed fever, redness, swelling to site 9x5 cm. No mottled appearance (blanches to touch)
vomited, mom placed in shower/tub to clean, started shivering, hands turned cold, fingers turned blue.  Mother repots chills, shaking, agitation, crying.  Temp 98.5 ax.  Slept well, but had increase temp at 6 a.m. on 11-14-06 99.5 decree
Quadriplegic from C5 down after an accident, subsequent neck surgery then meningitis, all in late 2005, has caretakers in his home. Unfortunately, one of his caretakers had COVID, having contact with him last Wednesday, January 5th. He has had increasing weakness, then febrile last 24 hrs and tachypneic. He received his second Moderna vaccine in September and di not think he was eligible yet for his 3rd shot. He was sleeping and on 2 L when I saw him with a sat of 88%, I turned up to 4L and up to 95%. We discussed treatment options and he is agreeable to Dex, Remdesivir and Baricitinib.  PT IS INPATIENT AT THIS TIME.
Chills and fever starting 9 hours after vaccine. Next morning fever. Very weak. Fever all day that day. Fever stopped middle of that night. I was fine next morning.
Staff member came into work morning after vaccination stated she had pain in right shoulder and chest that awakened her the night before. Also has swelling, tingling and throbbing in right hand that started the night of vaccine.
Numbness in hands and feet, weakness in legs and arms, (fell 4 times) before admission to hospital, numbness on tongue, face, lips about two weeks after flu shot.
Patient received Tdap vaccine on 7/26/2022 at facility. Patient had already received Tdap vaccine on 7/20/2022 at local pharmacy. 7/26/2022 patient verbalized no reactions or syptoms after 2nd dose administered.
Varicella vaccine administered 9/25/07. On 9/27/07 mother called to state that redness, swelling and small vesicles occurred around site of injection.
Information has been received from a registered nurse concerning a 5 year old female with no adverse event for the first dose of VARIVAX (Merck) (date not reported) who on 09-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot # was not provided), 0.5ml.  On 10-JUN-2009 the patient developed 1 and half inch rash at the injection site.  On 11-JUN-2009 the rash was 13 cm pink and red with deep center and physician confirmed that it was an allergic reaction.  The patient sought unspecified medical attention.  At the time of the report the patient had not recovered.  Follow up information has been received from a registered nurse concerning the patient with musical murmur and was well at time of vaccination who on 09-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot # 663948/0360Y) in right thigh.  Concomitant therapy included the second dose of MMR II ( lot # 663877/0356Y) in left thigh.  On 09-JUN-2009 the patient experienced 3cm cellulitis.  On 10-JUN-2009 the cellulitis grew to 13cm.  The area was red, swollen and warm to touch.  The patient was prescribed BENADRYL as needed every 4-6 hours.  At the time of the report the patient was recovered.  No further information is available.
Angina; Burning swollen pain in tonsils 1 minute after injection; Burning swollen pain in tonsils 1 minute after injection; cystic-like sore near tonsil; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16May2022 at 12:00 as dose 2, single (Lot number: FJ6369) at the age of 33 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: fruits" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing); "Recent diagnoses on HTN" (unspecified if ongoing), notes: Recent diagnoses on HTN. Concomitant medication(s) included: AMLODIPINE. Vaccination history included: BNT162b2 (previous dose details , previous dose product: COVID 19, previous dose brand: Pfizer, previous dose brand unknown: False, previous dose lot number: FJ6369, previous dose lot unknown: False, previous dose administration date: 28Jan2022, previous dose administration time: 08:00AM, previous dose dose number: 1, previous dose vaccine location: Left arm), administration date: 28Jan2022, when the patient was 33-year-old, for COVID-19 Immunization. The following information was reported: ANGINA PECTORIS (medically significant) with onset 16May2022 at 12:00, outcome "not recovered", described as "Angina"; BURNING SENSATION (non-serious), SWELLING (non-serious) all with onset 16May2022 at 12:00, outcome "not recovered" and all described as "Burning swollen pain in tonsils 1 minute after injection"; OROPHARYNGEAL PAIN (non-serious) with onset 16May2022 at 12:00, outcome "not recovered", described as "cystic-like sore near tonsil". The patient underwent the following laboratory tests and procedures: HTN: Unknown results, notes: Recent diagnoses on HTN. Therapeutic measures were not taken as a result of angina pectoris, burning sensation, swelling, oropharyngeal pain.  Additional information: report about covid vaccine was yes. If other vaccine in four weeks reported as No. other medications in two weeks reported as amlodipine 2.5 mg once a day. If covid prior vaccination reported as No. If covid tested post vaccination reported as No. Adverse event reported Burning swollen pain in tonsils 1 minute after injection, followed by cystic-like sore near tonsil. Angina.  Follow-up attempts are completed. No further information is expected.
ABOUT 15 MINUTES AFTER THE VACCINE, FEELING TINGLY IN TOES/LEGS/LEFT ARM/RIGHT FINGERS AND STRONGER TINGLING IN THE LEFT FINGERS; This spontaneous report received from a patient concerned a 50 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known allergies and was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1821288 expiry: UNKNOWN) dose was not reported, administered on 02-JUN-2021 16:00 for prophylactic vaccination. Concomitant medications included metoprolol. On 02-JUN-2021, the subject experienced about 15 minutes after the vaccine, feeling tingly in toes/legs/left arm/right fingers and stronger tingling in the left fingers. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from about 15 minutes after the vaccine, feeling tingly in toes/legs/left arm/right fingers and stronger tingling in the left fingers. This report was non-serious.
lower back pain for last 2 weeks since taking vaccine; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 06May2021 at 14:00 (Lot Number: er8736) as single dose for COVID-19 immunization. Medical history included hypertrophic cardiomyopathy and barretts esophagus. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Known allergies was none. Concomitant medication was reported as: The patient received the list of any other medications within 2 weeks of vaccination. On 11May2021, the patient experienced lower back pain for last 2 weeks since taking vaccine. The patient aware of no other activity or event that would be a cause. No treatment received. The outcome of event was not recovered.   No follow-up attempts are possible. No further information is expected.
Information has been received from a nurse referring to unspecified patients of unknown age. Patients' drug reaction and medical history were not reported. On an unknown date the patients experienced doses of ROTATEQ (lot # K013868, exp 27-MAY-2016; lot # K020182, exp 25-JUN-2016), which has been exposed to temperatures outside of the recommended range. There was no concomitant medication reported. At the time of the report, no adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative:  89yo male died on 9/23/2021 while inpatient hospice after inpatient admission on 9/12/2021 for covid pneumonia complicated by COPD. Pt had received covid vaccinations on 1/28/21 & 2/25/21 which failed prevention of covid infection. Per Md death report: "Death was caused by: Acute hypoxic respiratory failure from COVID Pneumonia complicated by underlying COPD"
She stated that she experienced some numbness to the tips of her fingers on her left hand. She stated she felt a dull pain and coldness to the deltoid area down to her elbow area on her left arm. She stated she had discomfort to the left side of her neck at her shoulder area. Ice pack applied.
I was assuming that I breezed through the vaccine, only mild arm soreness and fatigue and then on day 9 my arm began horrible itching and was sore to touch and felt warm.  When I got home, I removed my shirt to find that I had a large rash that developed at the vaccine site.  I immediately applied hydrocortisone creme and started googling this event to find out that there was a condition known as delayed covid vaccine rash.  The hydrocortisone creme was only slightly effective, it still itched like crazy.  The next day I phoned my doctors office and asked if they could prescribe an ointment that is stronger than the over the counter ointment.  He prescribed Triamcinolone Acetonide USP, 0/1%.  At first I didn't feel that the itching and swelling were subsiding but finally today, 5 days after onset, the ointment is working.  I still have the rash and it is still warm to touch but I think that it is improving. At the initial onset of the rash I started getting chills for the next few days and started feeling fatigued.  I don't feel like I'm  suffering from fatigue today but earlier today I  was getting chills.  It appears that   the chills are subsiding this evening.
Severe chills, sweat, nausea, headache, very dizzy for two days after shot.
About a month after my heart rate began to increase tremendously. A few weeks after that, I began getting chest pains, which radiated to my left arm and under my left breast. My doctor diagnosed me with Pericarditis in June 2021 and I was prescribe medication. In October of 2021 I had another diagnosis of pericarditis after experiencing the same chest pain, shortness of breath, speeding heart rate, pain that radiated to left arm and pain underneath my left breast.
At 2130 17 Oct 2012 shaking, chills, oral 102 temp. Injection site hot, inflamed, "hard" in spots, bruising. Saw MD two days later. Prescribed rest, fluids, ADVIL and script for KEFLEX for possible cellulitis. Has not taken KEFLEX.
This report was received from manufacturer for Infanrix and was assigned manufacturer report number A0492211A. This report concerned an 18 month old male with no reported medical history or concurrent conditions who was vaccinated in July 2000 with a first dose of hep B virus vaccine, in August 2000 with a second dose of 0.5ml of hep B virus vaccine (Engerix B) (lot 330A2) and on an unspecified date with a third dose of hep B virus vaccine. Concomitant therapy on unspecified dates included a series of Infanrix (961A2, 975A2, and 970A2) respectively. On 2/2/02 the pt was diagnosed with autism and "mercury in his body he can not excrete." The events were unresolved. Upon internal review autism and "mercury in his body he can not excrete" were considered to be other important medical events (OMIC). Additional info has been requested. This report was originally reported by a RN. It was reported that in approximately February 2002, at the child's decreased vocabulary. He only said "mama." If he wanted soething he would go and get it, but he did not verbalize his needs.  A developmental pediatric referral was given. On 02FEB2002, the patient was diagnosed with autism and "mercury in his body he cannot excrete". ON 07MAR2002 the patient had an audiology consult and mild hearing impairment was noted. In November 2002, at 28 months old, the patinet was seen by a developmental specialist. It was reported that he had delayed speech, sensory issues, distractibility, social impairment, communicaiton impairment, repetitive and restrictive interests, preoccupation, finger posturing, "mild stereotypes" and repetitive motor movements. He was diagnosed with autistic spectrum disorder. The patient was also given a diagnosis of pervasive developmental disorder. The nurse reported that the "mercury he can not excrete in his body" was a concern of the patient's mother. The mother ha dbeen asking about preservatives in vaccines and thought that htis may be his problem. Lab tests were never done and the nursd did not think that they planned to do any testing. It was also noted that at 3 years old in approximately June 2003, the child had acute shortness of breath and a cough after eating peanut butter. The patient went to the emergency room, was given diphenhydramine and epinephrine and was discharged. She indicated that he now keep epinephrine with him. Upon internal review, Autistic Spectrum Disorder, Pervasive Developmental Disorder, "mercury in his body he cannot excrete", and mild hearing impairment were considered to be other important medical events (OMIC). Additional information has been requested. This report was originally reported by a registered nurse. Follow up information received on 16MAR2004 contained the following adverse experience: cold symptoms (October 2001). This was origianlly reported by a registered nurse. Additional information has been requested.
Information has been received on 11-SEP-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2013, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a medical center as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. In 2014, the patient was treated at a medical center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Booster shot of Moderna was given to a 17 year old patient. No symptoms are shown and family was contacted to let them know about the mistake.
Type 2 diabetes mellitus well controlled, Blood in urine, Atrial fibrillation with rapid ventricular response., Pneumonia caused by SARS-CoV-2